TUCSON, Ariz.—Scientists in the University of Arizona Department of Physiology have identified a potential molecular mechanism that may hold the key to understanding how pressure is regulated in the eye. Funded by a $2.3 million five-year grant from the National Institutes of Health (NIH) National Eye Institute, this research could help to develop future treatments for glaucoma and other diseases. Current treatments focus on lowering eye pressure with eyedrops and oral medications. However, these drugs lose their effectiveness over time. More than three million Americans suffer from glaucoma, the second-leading cause of blindness in the U.S., according to Prevent Blindness America.

Read more